Abpro Bio Renames to RootK, Reverse Stock Split, and New Provision for Third-Party Treasury Share Disposal Raises Dilution Risk

Company name changed from Abpro Bio to RootK, par value doubled from 500 won to 1,000 won (2:1 reverse stock split), reducing outstanding shares from ~32.58M to ~16.29M with no change in market cap.
Business purpose amended: removed items like nuclear decommissioning and mask manufacturing, added entertainment businesses (music, performance, video production, advertising), diversifying operations.
Article 15 changed from share cancellation to holding/disposal of treasury shares, allowing the board to dispose of treasury shares to third parties without shareholder approval, significantly increasing potential dilution risk for existing shareholders.
Board size reduced from 3~11 to 3~7 directors, and new outside directors Lee Se-beom (CPA) and Lee Dong-heon (ex-CJ ENM, YG PLUS) appointed to strengthen audit committee.
Shareholder meeting rescheduled from June 5 to June 12, 2026, and electronic voting introduced for small shareholder convenience.
[AI Comprehensive Analysis]This charter amendment aims at business restructuring and governance improvement, but the introduction of third-party treasury share disposal poses a clear dilution risk to existing shareholders. While the reverse stock split is neutral, shareholders should be cautious about potential value erosion depending on management's future capital-raising decisions.